Other Ear, Nose, Mouth and Throat O.R. Procedures with CC DRG Reimbursement

DRG 144 encompasses other ear, nose, mouth and throat operating room procedures coded with a Complication or Comorbidity and reflects a higher clinical complexity within otolaryngology operative admissions. This classification influences inpatient reimbursement by assigning a higher payment relative weight when Complications or Comorbidities are present, which affects Medicare payment determinations.

DRG 144 Overview

DRG 144 covers inpatient cases involving other ear, nose, mouth and throat operating room procedures that are coded with a Complication or Comorbidity. Typical procedures include a range of otolaryngology operations that are more complex or that have additional clinical factors increasing resource use. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity raises the relative payment weight compared with cases without such comorbid conditions, affecting hospital reimbursement for inpatient stays.

Perioperative infection prevention and antibiotic stewardship trials focusing on preventing surgical site infections after complex ENT operative procedures: these studies enroll adult and pediatric patients undergoing ear, nose, mouth, and throat operations that carry higher risk of contamination or prosthetic implantation to test optimized perioperative antibiotic regimens, timing, and durations or alternative antiseptic protocols. The objective is to reduce postoperative infectious complications and readmissions in patients with comorbidities (eg, diabetes, immunosuppression) that increase CC-level risk; results are directly relevant to clinicians for guideline development and to payers for reducing costly complications and length of stay.
Comparative effectiveness studies of surgical approaches and airway management for complex ENT O.R. procedures with complications or comorbidities: these trials compare different operative techniques (eg, endoscopic versus open approaches), intraoperative monitoring strategies, or anesthetic/airway management protocols in patients with CC-level severity such as severe obstructive sleep apnea, recurrent infections, or prior surgery. The goal is to determine which approaches lead to fewer intraoperative complications, shorter operative time, and faster recovery, informing surgical decision-making and resource utilization that impact DRG costs and reimbursement.
Post-discharge functional outcomes and health services research assessing long-term morbidity, quality of life, and healthcare utilization after complex ENT operations: these prospective cohort studies follow patients with CCs (for example, recurrent otitis media with hearing loss or advanced sinonasal disease) to measure hearing, swallowing, speech outcomes, readmission rates, and outpatient service needs over months to a year. Findings help providers understand rehabilitation needs and guide care pathways to reduce readmissions and unnecessary post-acute services, and help payers model expected downstream costs and value-based payment strategies.

Perioperative infection prevention and antibiotic stewardship trials focusing on preventing surgical site infections after complex ENT operative procedures: these studies enroll adult and pediatric patients undergoing ear, nose, mouth, and throat operations that carry higher risk of contamination or prosthetic implantation to test optimized perioperative antibiotic regimens, timing, and durations or alternative antiseptic protocols. The objective is to reduce postoperative infectious complications and readmissions in patients with comorbidities (eg, diabetes, immunosuppression) that increase CC-level risk; results are directly relevant to clinicians for guideline development and to payers for reducing costly complications and length of stay.
Comparative effectiveness studies of surgical approaches and airway management for complex ENT O.R. procedures with complications or comorbidities: these trials compare different operative techniques (eg, endoscopic versus open approaches), intraoperative monitoring strategies, or anesthetic/airway management protocols in patients with CC-level severity such as severe obstructive sleep apnea, recurrent infections, or prior surgery. The goal is to determine which approaches lead to fewer intraoperative complications, shorter operative time, and faster recovery, informing surgical decision-making and resource utilization that impact DRG costs and reimbursement.
Post-discharge functional outcomes and health services research assessing long-term morbidity, quality of life, and healthcare utilization after complex ENT operations: these prospective cohort studies follow patients with CCs (for example, recurrent otitis media with hearing loss or advanced sinonasal disease) to measure hearing, swallowing, speech outcomes, readmission rates, and outpatient service needs over months to a year. Findings help providers understand rehabilitation needs and guide care pathways to reduce readmissions and unnecessary post-acute services, and help payers model expected downstream costs and value-based payment strategies.

OpenPayer

Summary & Overview

Other Ear, Nose, Mouth and Throat O.R. Procedures with CC: Inpatient Reimbursement Overview

DRG 144 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes